Navigation Links
Premier Research Names Bernard Sweeney as Executive Director, Medical Devices
Date:10/20/2009

tries across North America and Europe employing more 1,200 clinical professionals dedicated first and foremost to fulfilling each client's requirements in a timely, accurate, and cost-effective manner. This includes a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at our well-established network of dedicated clinical sites.

www.premier-research.com

SOURCE Premier Research Group Limited


'/>"/>
SOURCE Premier Research Group Limited
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Premier Micronutrient Launches Supplement for Hearing Health
2. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
3. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
4. Premier Research Honored as Clinical Research Team of the Year at 2008 GCPj Awards
5. Premier Research Announces Milestone New Drug Application
6. Premier Research Expands its Medical Device Operations to the United States
7. Premier Research Announces Milestone Investigational New Drug Application
8. Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress
9. Premier Heart Launches Multifunction CardioGram(TM) (MCG) In Latin America and the Caribbean
10. Premier Research Appoints Troy W. McCall, Ph.D. as Chief Executive Officer
11. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., Nov. 20 Cyberonics, In..., President and Chief Executive Officer, and Greg ...he 21st Annual Piper Jaffray Health Care Conferenc...:00 PM EST. The conference session and webcast wi...ented. Piper Jaffray will host a webcast of the p...
(Date:11/20/2009)...AKES, N.J., Nov. 20 BD (...y announced the completion of its acquisition of H...y that develops and manufactures molecular diagnos...2009, BD and HandyLab announced an exclusive agree... assays on the HandyLab Jaguar(TM) platform, the f...
(Date:11/20/2009)...N, N.J., Nov. 20 Soligen...the Company), formerly known as DOR BioPharma, Inc...oday that it has formed a consortium to develop th...er rapidly acting vaccines. Soligenix received a $...llergy and Infectious Diseases (NIAID), a division...
Breaking Medicine Technology:Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Reportlinker Adds Lung Cancer Therapeutics Report 56414 1Reportlinker Adds Lung Cancer Therapeutics Report 56414 2Reportlinker Adds Lung Cancer Therapeutics Report 56414 3Reportlinker Adds Lung Cancer Therapeutics Report 56414 4Reportlinker Adds Lung Cancer Therapeutics Report 56414 5Reportlinker Adds Lung Cancer Therapeutics Report 56414 6Reportlinker Adds Lung Cancer Therapeutics Report 56414 7Reportlinker Adds Lung Cancer Therapeutics Report 56414 8Reportlinker Adds Lung Cancer Therapeutics Report 56414 9Reportlinker Adds Lung Cancer Therapeutics Report 56414 10Reportlinker Adds Bariatric 28Obesity 29 Surgical Devices Report 56411 1Reportlinker Adds Bariatric 28Obesity 29 Surgical Devices Report 56411 2Reportlinker Adds Bariatric 28Obesity 29 Surgical Devices Report 56411 3Reportlinker Adds Bariatric 28Obesity 29 Surgical Devices Report 56411 4Reportlinker Adds Bariatric 28Obesity 29 Surgical Devices Report 56411 5Reportlinker Adds Bariatric 28Obesity 29 Surgical Devices Report 56411 6Reportlinker Adds Bariatric 28Obesity 29 Surgical Devices Report 56411 7Reportlinker Adds Bariatric 28Obesity 29 Surgical Devices Report 56411 8Reportlinker Adds Bariatric 28Obesity 29 Surgical Devices Report 56411 9Reportlinker Adds Bariatric 28Obesity 29 Surgical Devices Report 56411 10Reportlinker Adds Bariatric 28Obesity 29 Surgical Devices Report 56411 11Reportlinker Adds Bariatric 28Obesity 29 Surgical Devices Report 56411 12Image Sensors 2009 Offers Promotional Discount on Machine Vision and Wireless Power Summits 56410 1Image Sensors 2009 Offers Promotional Discount on Machine Vision and Wireless Power Summits 56410 2Image Sensors 2009 Offers Promotional Discount on Machine Vision and Wireless Power Summits 56410 3
...mpson Presented Results at The Sixth International...ncies in New York City - , , - Detailed Efficacy ... , , KNOXVILLE, Tenn., March 16 Provectus Phar...velopment-stage oncology and dermatology biopharma...y and efficacy results from the first 20 subjects ...
... less likely to need emergency room treatment or h... , , Study is first in a series to examine factor... , , FRANKLIN LAKES, N.J., March 14 Results of a... the American Academy of Asthma, Allergy and Immun...y room (ER) visits and hospitalizations for asthma...
Other Medicine Technology:Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results 2Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results 3Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results 4New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits 2New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits 3New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits 4
(Date:11/20/2009)... Senators and Congressmen in Competitive R...Health Care Vote , Washin... congressmen running for re-election next year in ...harlie Cook, may come to regret voting for House S...rding to a breaking Zogby International/ O’L...
(Date:11/20/2009)...N-SALEM, N.C., Nov. 20 ...ion to redefine what it means to be "happy" during...r with a specialty in family counseling and chair ...versity, Gladding says research shows that it is t...s and even depression during the holidays. ,, T...
(Date:11/20/2009)...sure readings in children with chronic kidney dise... doctor,s office visits increasing a child,s risk... from Johns Hopkins Children,s Center and other in...e in the Journal of American Society of Nephrology...ements obtained during regular doctor visits to re...
(Date:11/20/2009)...nds more severe cases than with seasonal flu , ...dian researchers are reporting that children with ...H1N1 flu than seasonal flu. , "Asthma has been ...ion with pandemic H1N1 influenza, present in 21 pe...Dr. Upton Allen and fellow researchers from the Ho...
(Date:11/20/2009)...NTAIN VIEW, Calif., Nov. 20 /PRNewswire-FirstCall/...ider of system solutions to acute healthcare facil... the 21st Annual Piper Jaffray Healthcare Confere... ,, Omnicell Speakers: Randall A. Lipps, foun...ice president & CFO ,, Date: Tuesday, Dec...
Breaking Medicine News(10 mins):Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:High blood pressure easy to miss in children with kidney disease 2Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2
...Services, Inc. (NYSE: WST ) today announced that...xecutive Officer, and William Federici, Chief Fina...Global Specialty Pharmaceuticals Conference at 9:0... Company,s website at www.westpharma.com . , ,...
...ew report that warns of potential liver damage fro...s of natural pain relief products are picking up s...commending stronger warnings and dose limits for d... several years now, which has led to new natural a...
...nd display whilst visiting loved ones in hospital ...ew research released by The Co-operative ISA,s. , ... deals, with 1 in 6 (17 per cent) people citing fe...efusing to pay. , , Having to pay to spend a penn...
... the National Institutes of Health (NIH), Elias A....of Trustees. Dr. Zerhouni, who directed the NIH fr...his first meeting as a board member on May 8th in ...erience and expertise that will be of great value ...
...n,t short-lived, new study shows , , FRIDA...sting your mood, exercise is the gift that keeps o...act, the feel-good afterglow a workout brings may ... can last up to 12 hours," concluded study lead re...
...y (NYSE: LLY ) announced today that the European... Products for Human Use (CHMP) has issued a positi...r injection) as monotherapy for the maintenance tr...isease has not progressed immediately following pl...
Other Medicine News:Health News:Buster Brands Launches Natural Alternatives to Acetaminophen Pain Killers 2Health News:Hospital Car Parking Fees Top the List of Life's Biggest Injustices 2Health News:Former NIH Head Joins Mayo Clinic Trustees 2Health News:Post-Exercise 'Glow' May Last 12 Hours 2Health News:Post-Exercise 'Glow' May Last 12 Hours 3Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 2Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 3Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 4Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 5Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 6Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 7
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: